209:
48:
252:
336:
226:
41:
331:
177:
214:
125:
185:
158:
104:
110:
78:
26:
144:
256:
61:
220:
87:
325:
266:
120:
95:
69:
17:
195:
149:
134:
100:
190:
163:
57:
139:
65:
294:
will show the template collapsed, i.e. hidden apart from its title bar.
259:), it is hidden apart from its title bar; if not, it is fully visible.
251:, meaning that if there is another collapsible item on the page (a
30:
318:
will show the template expanded, i.e. fully visible.
297:
273:
176:
119:
86:
77:
262:To change this template's initial visibility, the
42:
8:
83:
49:
35:
27:
246:initial visibility currently defaults to
263:
7:
257:table with the collapsible attribute
25:
1:
353:
204:
337:Drug templates by ATC
178:Contraction induction
18:Template:Uterotonic
231:Never to phase III
241:
240:
172:
171:
111:Methylergometrine
79:Cervical ripening
16:(Redirected from
344:
317:
316:
312:
309:
306:
303:
300:
293:
292:
288:
285:
282:
279:
276:
265:
264:|state=
249:
244:This template's
84:
51:
44:
37:
28:
21:
352:
351:
347:
346:
345:
343:
342:
341:
332:Obstetric drugs
322:
321:
314:
310:
307:
304:
301:
298:
290:
286:
283:
280:
277:
274:
253:navbox, sidebar
247:
242:
237:
236:
221:Clinical trials
200:
168:
152:
145:Dinoprostone/E2
124:
115:
88:Ergot alkaloids
73:
55:
23:
22:
15:
12:
11:
5:
350:
348:
340:
339:
334:
324:
323:
320:
319:
295:
239:
238:
235:
234:
233:
232:
229:
218:
212:
206:
205:
202:
201:
199:
198:
193:
188:
182:
180:
174:
173:
170:
169:
167:
166:
164:Carboprost/F2α
161:
154:
153:
150:Sulprostone/E2
147:
142:
137:
135:Misoprostol/E1
130:
128:
121:Prostaglandins
117:
116:
114:
113:
108:
98:
92:
90:
81:
75:
74:
62:labor inducers
56:
54:
53:
46:
39:
31:
24:
14:
13:
10:
9:
6:
4:
3:
2:
349:
338:
335:
333:
330:
329:
327:
296:
272:
271:
270:
269:may be used:
268:
260:
258:
254:
250:
230:
228:
225:
224:
222:
219:
216:
213:
211:
208:
207:
203:
197:
194:
192:
189:
187:
184:
183:
181:
179:
175:
165:
162:
160:
159:Dinoprost/F2α
156:
155:
151:
148:
146:
143:
141:
138:
136:
132:
131:
129:
127:
122:
118:
112:
109:
106:
102:
99:
97:
94:
93:
91:
89:
85:
82:
80:
76:
71:
67:
63:
59:
52:
47:
45:
40:
38:
33:
32:
29:
19:
261:
248:autocollapse
245:
243:
140:Gemeprost/E1
105:Syntometrine
96:Acetergamine
34:
302:Uterotonics
278:Uterotonics
217:from market
196:Demoxytocin
101:Ergometrine
58:Uterotonics
326:Categories
191:Carbetocin
289:collapsed
267:parameter
227:Phase III
215:Withdrawn
126:analogues
66:oxytocics
313:expanded
186:Oxytocin
210:WHO-EM
308:state
284:state
255:, or
70:G02A
157:F:
133:E:
123:and
328::
315:}}
299:{{
291:}}
275:{{
223::
311:=
305:|
287:=
281:|
107:)
103:(
72:)
68:(
64:/
60:/
50:e
43:t
36:v
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.